Swiss biotech startup that combines AI and molecular simulation to discover drugs faster.
🇨🇭 Lugano, Switzerland · Founded 2024 · 11–50 people
InVirtuoLabs is a biotech startup founded in Lugano, Switzerland, in 2024. Its legal name is In Virtuo Laboratories SA. It combines machine learning, including generative chemistry, with physics-based molecular simulations to find and optimize drug candidates. The company runs its own drug discovery projects, offers its virtual laboratory platform, and co-develops drugs with pharmaceutical companies. It is supported by the USI Startup Centre incubation program.
Co-development with pharmaceutical companies is one of the three pillars of its business model, and it already works with several pharmaceutical and biotech firms on co-development projects.
End-to-end AI drug discovery platform that combines machine learning with physics-based molecular simulations.
Who it's for: Pharmaceutical and biotech companies
Joint R&D projects in which the platform is used to design and optimize drug candidates for a partner.
Who it's for: Pharmaceutical and biotech companies
In-house drug candidates for metabolic and neurological disorders.
Pharmaceutical and biotech companies that work with InVirtuoLabs on co-development projects.